139 related articles for article (PubMed ID: 21516305)
21. Red blood cell depletion from bone marrow and peripheral blood buffy coat: a comparison of two new and three established technologies.
Sorg N; Poppe C; Bunos M; Wingenfeld E; Hümmer C; Krämer A; Stock B; Seifried E; Bonig H
Transfusion; 2015 Jun; 55(6):1275-82. PubMed ID: 25647556
[TBL] [Abstract][Full Text] [Related]
22. Separation of platelet concentrates (PC) from buffy coat (BC) using the bottom and top drainage (BAT) system.
Kretschmer V; Biermann E; Loh H
Beitr Infusionsther; 1990; 26():65-70. PubMed ID: 1703903
[TBL] [Abstract][Full Text] [Related]
23. Platelet activation of platelet concentrates derived from buffy coat and apheresis methods.
Ali SF
Transfus Apher Sci; 2011 Feb; 44(1):11-3. PubMed ID: 21277261
[TBL] [Abstract][Full Text] [Related]
24. Automated preparation of platelet concentrates from pooled buffy coats: in vitro studies and experiences with the OrbiSac system.
Larsson S; Sandgren P; Sjödin A; Vesterinen M; Gulliksson H
Transfusion; 2005 May; 45(5):743-51. PubMed ID: 15847664
[TBL] [Abstract][Full Text] [Related]
25. In-process cell counts during preparation of platelet concentrates from buffy coats.
Stampfli R; Schaller M; Schenker T; Frey-Wettstein M; Hauser SP; Nydegger UE
Transfus Sci; 1997 Dec; 18(4):495-503. PubMed ID: 10178672
[TBL] [Abstract][Full Text] [Related]
26. Automated separation of cord blood units in top and bottom bags using the Compomat G4.
Solves P; Mirabet V; Carbonell-Uberos F; Soler MA; Roig R
Clin Lab Haematol; 2006 Jun; 28(3):202-7. PubMed ID: 16706938
[TBL] [Abstract][Full Text] [Related]
27. Platelet concentrates from buffy coats: improved conditions for preparation and evaluation in routine clinical use.
Rebulla P; Bertolini F; Porretti L; Marangoni F; Smacchia C; Marconi M; Riccardi D; Sirelson V; Pappalettera M; Sirchia G
Transfus Sci; 1993 Jan; 14(1):41-6. PubMed ID: 10148312
[TBL] [Abstract][Full Text] [Related]
28. Leucoreduced platelet concentrates in additive solution: an evaluation of filters and storage containers.
van der Meer P; Pietersz R; Reesink H
Vox Sang; 2001; 81(2):102-7. PubMed ID: 11555469
[TBL] [Abstract][Full Text] [Related]
29. Effect of holding buffy coats 4 or 18 hours before preparing pooled filtered PLT concentrates in plasma.
Pérez-Pujol S; Lozano M; Perea D; Mazzara R; Ordinas A; Escolar G
Transfusion; 2004 Feb; 44(2):202-9. PubMed ID: 14962311
[TBL] [Abstract][Full Text] [Related]
30. [Quality of buffy-coat-derived platelet concentrates prepared using automated system terumo automated centrifuge and separator integration (TACSI)].
Zebrowska A; Lipska A; Rogowska A; Bujno M; Nedzi M; Radziwon P
Pol Merkur Lekarski; 2011 Mar; 30(177):191-4. PubMed ID: 21544996
[TBL] [Abstract][Full Text] [Related]
31. A novel technique for preparing improved buffy coat platelet concentrates.
Mrowiec ZR; Oleksowicz L; Dutcher JP; De Leon-Fernandez M; Lalezari P; Puszkin EG
Blood Cells Mol Dis; 1995; 21(1):25-33. PubMed ID: 7655858
[TBL] [Abstract][Full Text] [Related]
32. Platelet concentrates in an additive solution prepared from pooled buffy coats. 1. In vitro studies.
Eriksson L; Högman CF
Vox Sang; 1990; 59(3):140-5. PubMed ID: 2264316
[TBL] [Abstract][Full Text] [Related]
33. Are all leucodepleted platelet concentrates equivalent? Comparison of Cobe LRS Turbo, Haemonetics MCS+ LD, and filtered pooled buffy-coat-derived platelets.
Krailadsiri P; Seghatchian J
Vox Sang; 2000; 78(3):171-5. PubMed ID: 10838518
[TBL] [Abstract][Full Text] [Related]
34. Leukoreduction of platelet concentrates using a 'polishing' filter.
van der Meer PF; Pietersz RN; Reesink HW
Vox Sang; 2000; 79(1):27-33. PubMed ID: 10971211
[TBL] [Abstract][Full Text] [Related]
35. In vitro variables of buffy coat-derived platelet concentrates with residual plasma of down to 10% are stably maintained in new-generation platelet additive solutions.
Gravemann U; Volgmann T; Min K; Philipp R; Lambrecht B; Müller TH; Seltsam A
Transfusion; 2015 Jul; 55(7):1700-9. PubMed ID: 25677807
[TBL] [Abstract][Full Text] [Related]
36. Quality assessment of buffy-coat-derived leucodepleted platelet concentrates in PAS-plasma, prepared by the OrbiSac or TACSI automated system.
Plaza EM; Céspedes P; Fernández H; Sánchez-Guiu MI; Egea JM; Vicente V; Lozano ML; Rivera J
Vox Sang; 2014 Jan; 106(1):38-44. PubMed ID: 23888911
[TBL] [Abstract][Full Text] [Related]
37. Blood component fractionation: manual versus automatic procedures.
Pasqualetti D; Ghirardini A; Cristina Arista M; Vaglio S; Fakeri A; Waldman AA; Girelli G
Transfus Apher Sci; 2004 Feb; 30(1):23-8. PubMed ID: 14746818
[TBL] [Abstract][Full Text] [Related]
38. Improvement of blood component quality--automatic separation of blood components in a new bag system.
Kretschmer V; Khan-Blouki K; Biermann E; Söhngen D; Eckle R
Infusionstherapie; 1988 Dec; 15(6):232-9. PubMed ID: 3235201
[TBL] [Abstract][Full Text] [Related]
39. Characterization of blood components separated from donated whole blood after an overnight holding at room temperature with the buffy coat method.
Lu FQ; Kang W; Peng Y; Wang WM
Transfusion; 2011 Oct; 51(10):2199-207. PubMed ID: 21492181
[TBL] [Abstract][Full Text] [Related]
40. Variable leukocyte composition of red blood cell concentrates prepared in top-bottom systems: possible implications for pre-transplant blood transfusion.
Weinreich SS; Remmerswaal EB; Laport R; van Rhenen DJ; Rombout-Sastrienkova E; Smit Sibinga CT; Vrielink H; Boog CJ
Vox Sang; 2000; 79(2):83-6. PubMed ID: 11054045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
